+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Middle-East and Africa Blood Glucose Monitoring Market - Growth, Trends, and Forecasts (2020 - 2025)

  • ID: 5175762
  • Report
  • August 2020
  • Region: Africa
  • 90 pages
  • Mordor Intelligence
UP TO OFF
until Dec 31st 2020

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott
  • Agamatrix Inc.
  • Bionime Corporation
  • F. Hoffmann-La Roche AG
  • Johnson & Johnson
  • Medtronics
  • MORE
The Middle-East and Africa blood glucose monitoring market is expected to register a CAGR of over 12%, during the forecast period (2020 - 2025). The market is estimated to reach above USD 294 million by 2020. There is an increasing incidence of lifestyle diseases, such as diabetes, in developing countries that are increasing the demand for blood glucose monitoring devices. The increased awareness about healthcare facilities and preventive care is also supporting the growth of the market. The number of patients relying on self-monitoring blood glucose (SMBG) has increased. Owing to the high-cost constraints associated with the continuous glucose monitoring (CGM), self-monitoring by glucometer is more acceptable in the Middle-East and Africa region. These devices help in the early detection of hypo and hyperglycemia conditions, which tend to drive the market for glucose monitoring.

Key Market Trends

Test Strips Accounted for the Highest Market Share in Middle-East and Africa BGM Market

In the Middle-East and Africa blood glucose monitoring market, test strips hold 49% of the share with USD 127 million revenue. Price is often a significant concern for the purchase of blood glucose test strips. Although various countries provide reimbursements for prescribed test strips, a majority of the patients have to pay for them from their pockets. Africa is experiencing a rise in the number of diabetic patients over the past decade. Total diabetes-related health expenditure in Africa is close to USD 9,500 million, which is expected to almost double by 2045. Programs, such as the Base of the Pyramid project, a public-private partnership initiated by Novo Nordisk aims to increase the awareness about diabetes in low- and middle-income countries in Africa.​ In Middle-East and Africa, due to lifestyle and food habits, blood glucose fluctuations among insulin users are frequent from time to time, and the usage of self-monitoring of blood glucose increases. ​

Saudi Arabia and Iran Together Accounted for over 50% Share in the Middle-East and Africa Blood Glucose Monitoring Market

The leading market in the Middle-East and Africa Blood Glucose Monitoring Market is Saudi Arabia with a 36% market share followed by Iran and others. The high sales of Blood Glucose Monitoring Devices in Saudi Arabia is due to the growing prevalence of diabetes in the country. The Middle-East countries have high diabetes prevalence like Saudi Arabia 24%, Kuwait 23%, Bahrain 22%, Qatar 20%, and UAE 19% approximately. Price is often a significant concern for the purchase of Blood Glucose Monitoring Devices. Although various countries, like Saudi Arabia, Iran, and other countries in Middle-East and Africa provide reimbursements for prescribed SMBG devices and their components, the majority of the patients have to pay for them from their pockets.

Competitive Landscape

The Middle-East and Africa blood glucose monitoring market is highly fragmented with few major manufacturers boasting a global market presence, while the remaining manufacturers are confining to the other local or region-specific manufacturers, and the local government initiatives encouraging the market. For Instance, in September 2019, Saudi Arabia Ministry of Health launched Population Health Management in collaboration with Philips VitalHealth and government-owned Lean for Business Services. This program will enable the Ministry of Health to screen 500,000 patients diagnosed with diabetes and hypertension.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott
  • Agamatrix Inc.
  • Bionime Corporation
  • F. Hoffmann-La Roche AG
  • Johnson & Johnson
  • Medtronics
  • MORE
1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.3 Market Restraints
4.4 Porter's Five Forces Analysis
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Consumers
4.4.3 Threat of New Entrants
4.4.4 Threat of Substitute Products and Services
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 Self-monitoring Blood Glucose
5.1.1 By Component (Value and Volume, 2012-2025)
5.1.1.1 Glucometer Devices
5.1.1.2 Test Strips
5.1.1.3 Lancets
5.2 Continuous Glucose Monitoring
5.2.1 By Component (Value and Volume, 2012-2025)
5.2.1.1 Sensors
5.2.1.2 Durables
5.3 By Geography
5.3.1 Middle-East and Africa
5.3.1.1 Saudi Arabia (Value and Volume, 2012-2025)
5.3.1.1.1 Self-monitoring Blood Glucose
5.3.1.1.1.1 By Component (Glucometer Device, Test strips, Lancets)
5.3.1.1.2 Continuous Glucose Monitoring
5.3.1.1.2.1 By Component (Sensors and Durables)
5.3.1.2 Iran (Value and Volume, 2012-2025)
5.3.1.2.1 Self-monitoring Blood Glucose
5.3.1.2.1.1 By Component (Glucometer Device, Test strips, Lancets)
5.3.1.2.2 Continuous Glucose Monitoring
5.3.1.2.2.1 By Component (Sensors and Durables)
5.3.1.3 Egypt (Value and Volume, 2012-2025)
5.3.1.3.1 Self-monitoring Blood Glucose
5.3.1.3.1.1 By Component (Glucometer Device, Test strips, Lancets)
5.3.1.3.2 Continuous Glucose Monitoring
5.3.1.3.2.1 By Component (Sensors and Durables)
5.3.1.4 Oman (Value and Volume, 2012-2025)
5.3.1.4.1 Self-monitoring Blood Glucose
5.3.1.4.1.1 By Component (Glucometer Device, Test strips, Lancets)
5.3.1.4.2 Continuous Glucose Monitoring
5.3.1.4.2.1 By Component (Sensors and Durables)
5.3.1.5 South Africa (Value and Volume, 2012-2025)
5.3.1.5.1 Self-monitoring Blood Glucose
5.3.1.5.1.1 By Component (Glucometer Device, Test strips, Lancets)
5.3.1.5.2 Continuous Glucose Monitoring
5.3.1.5.2.1 By Component (Sensors and Durables)
5.3.1.6 Rest of Middle-East and Africa (Value and Volume, 2012-2025)
5.3.1.6.1 Self-monitoring Blood Glucose
5.3.1.6.1.1 By Component (Glucometer Device, Test strips, Lancets)
5.3.1.6.2 Continuous Glucose Monitoring
5.3.1.6.2.1 By Component (Sensors and Durables)

6 MARKET INDICATORS
6.1 Type-1 Diabetes population (2012-2025)
6.2 Type-2 Diabetes population (2012-2025)

7 COMPETITIVE LANDSCAPE
7.1 Company Profiles
7.1.1 Abbott
7.1.2 F. Hoffmann-La Roche AG
7.1.3 Johnson & Johnson
7.1.4 Dexcom
7.1.5 Medtronics
7.1.6 Agamatrix Inc.
7.1.7 Bionime Corporation
7.1.8 Acon
7.1.9 Medisana
7.1.10 Trivida
7.1.11 I-SENS
7.1.12 Ascensia
7.1.13 Rossmax

8 MARKET OPPORTUNITIES AND FUTURE TRENDS
Note: Product cover images may vary from those shown

Loading
LOADING...

  • Abbott
  • F. Hoffmann-La Roche AG
  • Johnson & Johnson
  • Dexcom
  • Medtronics
  • Agamatrix Inc.
  • Bionime Corporation
  • Acon
  • Medisana
  • Trivida
  • I-SENS
  • Ascensia
  • Rossmax
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll